Navigation Links
MAQUET Cardiovascular Announces Patent Infringement Complaints Against Terumo
Date:4/1/2008

SAN JOSE, Calif., April 1, 2008 /PRNewswire/ -- MAQUET Cardiovascular LLC today announced that it filed concurrent patent infringement complaints in the United States International Trade Commission and the U.S. District Court for the District of Northern California against Terumo Corporation and Terumo Cardiovascular Systems Corporation. The complaints allege that Terumo infringes two MAQUET U.S. patents through the manufacture, use, sale, and/or importation of its VirtuoSaph(TM) endoscopic vessel harvesting (EVH) system. The ITC case seeks to exclude the infringing products from importation into the United States and the district court case seeks monetary damages and an injunction.

During heart bypass surgery, the surgeon removes part of a healthy blood vessel from the patient and uses it to create a new blood flow path in the heart. MAQUET Cardiovascular is the market leader in EVH with its VASOVIEW(R) products, which enable a cardiovascular surgeon to remove a patient's vessel less invasively, typically from the leg. EVH has been demonstrated to reduce wound complications, shorten hospital stays, and significantly minimize scarring compared to open harvesting techniques. EVH can help patients regain mobility more quickly, which contributes to their overall recovery and future heart health.

"MAQUET, and its predecessors, have pioneered eight generations of EVH products -- each built on our proprietary technology that delivers demonstrated efficacy, safety, and reliability," said Patrick T. Walsh, Executive Vice President and Chief Operating Officer of MAQUET Cardiovascular LLC. "As our patients rely on this technology for quicker recovery after heart bypass surgery, we must defend our intellectual property assets so that we can continue EVH innovation."

About MAQUET Cardiovascular

MAQUET Cardiovascular LLC is a division of MAQUET Medical Systems, part of the publicly listed Swedish group of companies GETINGE AB. MAQUET Cardiovascular was recently formed by combining MAQUET Cardiopulmonary with Boston Scientific's Vascular Surgery and Cardiac Surgery divisions, which includes the products and services of Guidant Cardiac Surgery. The creation of this new organization enables MAQUET to offer a comprehensive array of patient care solutions for less-invasive endoscopic vessel harvesting, off- and on- pump coronary artery bypass surgery, and vascular grafts.

MAQUET has 170 years of healthcare experience, and is committed to becoming "The Gold Standard" for therapeutic medical equipment across the globe. As a market leader, MAQUET offers innovative medical solutions from three divisions: Surgical Workplaces, Critical Care, and Cardiovascular.

MAQUET Medical Systems is headquartered in Rastatt, Germany and employs 4,100 employees, has more than 30 international sales and service subsidiaries, and a network of over 200 dealer distributors worldwide. For more information, please visit http://www.maquet.com and http://www.getinge.com.


'/>"/>
SOURCE MAQUET Cardiovascular LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ARJO / Getinge / Maquet Announces New West Coast Showroom Opening
2. 2-drug blood pressure therapy lowers cardiovascular risk
3. Decreased sexual satisfaction is not associated with cardiovascular disease in postmenopausal women
4. Mary Matalin and John Ray Join the Cheney Cardiovascular Institute Board of Directors
5. Eric J. Topol, M.D., to Present Late-Breaking Lecture About Advancements in Genomics of Cardiovascular Disease at ACCs 57th Annual Scientific Session
6. Medical Simulation Corporation to Present Comprehensive Cardiac Patient Scenario at the Society for Cardiovascular Angiography and Interventions (SCAI) and American College of Cardiology (ACC) Conference
7. Study finds certain liver disease related to cardiovascular fitness
8. Randy Jackson and the American Heart Association Educate Raleigh Area Residents About the Connection Between Type 2 Diabetes and Cardiovascular Disease
9. Cardiovascular nursing: Striving for excellence in the care of cardiac patients
10. Glaucoma May Boost Cardiovascular Death Risk in Blacks
11. Mayo Clinic proceedings highlights research about cardiovascular benefits of omega-3 fatty acids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... VA (PRWEB) , ... February ... ... of Change for Devicemakers , Sponsored by Axendia, **FDAnews Free Webinar**, March ... , Are manufacturers looking to reduce their regulatory burden? Pay dividends in ...
(Date:2/18/2017)... ... 2017 , ... Butler Mobility invited Ken Matthews to visit its manufacturing facility ... Ken was impressed with the safety and reliability of the Stannah Stairlift as well ... This endorsement by Ken Matthews can be heard on News Radio WHP 580 ...
(Date:2/18/2017)... ... February 17, 2017 , ... Park Cities Pet Sitter President, Joette White, has ... Life Radio network. The episode, which was posted this week, features a 30-minute ... led to Park Cities Pet Sitter’s being awarded the 2017 National Association of Professional ...
(Date:2/18/2017)... ... February 18, 2017 , ... ... latest information and contact points to easily connect elderly veterans of America's armed ... and elder-care funding. It also conveys material on this year's increase in the ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... ... has not kept pace. Enovate Medical has introduced an innovative workstation designed to ... of supporting nurses, the Encore Mobile EHR Workstation offers a lightweight, highly mobile, ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... 17, 2017   Risperdal lawsuits involving gynecomastia (male ... with use of the atypical antipsychotic medication continue to ... Court of Common Pleas, where the state,s Risperdal docket ... to a notice posted on the Court,s website ... on March 9, 2017 at 11:00 a.m. (In Re: ...
(Date:2/17/2017)... Feb. 17, 2017  Featuring new ... at the  2017 HIMSS Conference & Exhibition (HIMSS17 ),  ... a global leader in health ... of population health management, acute healthcare ... integrated in a highly secure, cloud-based ...
(Date:2/17/2017)... 17, 2017  Noble Capital Markets announced today that ... (Nasdaq: EPIX ). The report was issued ... , PhD. ESSA Pharmaceuticals is a clinical ... cancer (CRPC). Its lead compound EPI-506, is a small ... of the androgen receptor, thereby has potential to overcome ...
Breaking Medicine Technology: